PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Ent2 108 Target Target Equilibrative Nucleoside Transporter 1 211 15 0.10 -0.89 0.14 0.84
CCL2 3,560 Target Target CXCL9 1,016 190 0.10 -0.88 0.19 0.80
BMX 185 Target Target BTK 1,263 49 0.10 -0.84 0.26 0.80
Eotaxin 2,457 Target Target Eotaxin-3/CCL26 26 26 0.10 -0.19 1.00 0.77
BD3 32 Target Target BD4 26 3 0.10 -0.90 0.12 0.86
CD4 112,219 Target Disease Infection 766,637 30,996 0.11 -0.83 0.28 0.68
Epidermal Growth Factor Receptor 24,772 Target Disease Non Small Cell Lung Cancer 28,563 2,827 0.11 -0.89 0.11 0.78
CXCL10/IP-10 114 Target Target CXCL9 1,016 37 0.11 -0.81 0.32 0.81
CD1A 2,739 Target Target CD68 6,424 458 0.11 -0.88 0.17 0.80
CCL2 3,560 Target Target CCL8 197 92 0.11 -0.72 0.47 0.78
Dihydropteroate Synthase 408 Target Target Dihydrofolate Reductase 5,563 166 0.11 -0.76 0.41 0.78
CXCL10/IP-10 114 Target Target CXCL11 526 27 0.11 -0.85 0.24 0.82
CRG-2 41 Target Target CRG-10 2 1 0.11 -0.70 0.50 0.83
CEA 17,022 Target Target CA 15-3 898 437 0.11 -0.71 0.49 0.76
CCL2 3,560 Target Target CXCL2 750 192 0.12 -0.84 0.26 0.80
CCL3 1,427 Target Target CXCL2 750 123 0.12 -0.87 0.16 0.83
CCL18 256 Target Target DC-CK1 22 9 0.12 -0.76 0.41 0.82
AMY2B 21 Target Target AMY1A 13 2 0.12 -0.87 0.15 0.87
Bile Salt Export Pump 476 Target Target Multidrug Resistance-Associated Protein 2 462 57 0.12 -0.88 0.12 0.85
CXCL10/IP-10 114 Target Target CXCL4/PF4 9 4 0.12 -0.73 0.44 0.83
CCL5 2,002 Target Target CXCL9 1,016 180 0.13 -0.87 0.18 0.83
Artemin 184 Target Target Enovin 3 3 0.13 -0.50 1.00 0.81
CCL3 1,427 Target Target CXCL10 2,386 238 0.13 -0.87 0.17 0.83
4-1BB Ligand 135 Target Target CD137 474 33 0.13 -0.84 0.24 0.84
BMP-6 386 Target Target BMP-2 3,889 163 0.13 -0.74 0.42 0.80
EPHB3 118 Target Target EPHB1 137 17 0.13 -0.87 0.14 0.87
Tissue-Type Plasminogen Activator 5,020 Target Target Urokinase-Type Plasminogen Activator 3,939 603 0.14 -0.86 0.15 0.83
Androgen Receptor 12,918 Target Disease Prostate Cancer 71,064 4,112 0.14 -0.80 0.32 0.76
BAFF 1,240 Target Target BAFFR 44 33 0.14 -0.49 0.75 0.80
BMP-7 1,112 Target Target BMP-4 1,255 169 0.14 -0.86 0.15 0.85
Antithrombin 13,773 Target Target D-Dimer 6,185 1,337 0.14 -0.84 0.22 0.81
Angiotensin Converting Enzyme 31,674 Target Target Angiotensin-Converting Enzyme 2 665 665 0.14 -0.04 1.00 0.76
BMP-6 386 Target Target BMP-7 1,112 95 0.15 -0.83 0.25 0.84
BMP-6 386 Target Target BMP-4 1,255 101 0.15 -0.82 0.26 0.83
D(1a) Dopamine Receptor 51 Target Target D(2) Dopamine Receptor 1,559 41 0.15 -0.44 0.80 0.80
bFGF 9,327 Target Target aFGF 899 448 0.15 -0.69 0.50 0.79
Alpha-Glucosidase 4,319 Target Target Lysosomal Alpha-Glucosidase 105 105 0.16 -0.10 1.00 0.79
BMP-7 1,112 Target Target BMP-2 3,889 338 0.16 -0.80 0.30 0.82
CCL7 274 Target Target CCL2 3,560 164 0.17 -0.62 0.60 0.81
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
ApoE2 517 Target Target APOE 12,771 454 0.18 -0.34 0.88 0.78
Ck-beta-11 4 Target Target Exodus-3 8 1 0.18 -0.81 0.25 0.89
Epidermal Growth Factor Receptor 24,772 Target Target EGF 27,487 4,679 0.18 -0.82 0.19 0.82
BMP-4 1,255 Target Target BMP-2 3,889 399 0.18 -0.78 0.32 0.83
CCL2 3,560 Target Target CXCL10 2,386 530 0.18 -0.81 0.22 0.85
Angiotensin Converting Enzyme 31,674 Target Target Renin 43,456 6,899 0.19 -0.81 0.22 0.81
EPHB2 385 Target Target EPHB1 137 43 0.19 -0.78 0.31 0.86
CCL4 5,638 Target Target CCL3 1,427 535 0.19 -0.75 0.37 0.83
AMAC-1 19 Target Target DC-CK1 22 4 0.20 -0.80 0.21 0.90
BD2 76 Target Target BD3 32 10 0.20 -0.77 0.31 0.88